INTF - ETF AI Analysis

Top Page

iShares MSCI Intl Multifactor ETF (INTF)

Rating:64Neutral

Price Target:―

INTF’s rating suggests it is a solid, but not top-tier, international multifactor ETF, supported by strong core holdings like Novartis and AstraZeneca, which benefit from robust financial performance, healthy pipelines or product approvals, and generally positive outlooks. Financial giants such as HSBC, Mitsubishi UFJ, and Royal Bank of Canada also add stability through solid profitability and reasonable valuations, though some face concerns like high leverage or potential overbought conditions. The main risk factor is that several key holdings show signs of rich valuations or overbought technicals, which could limit near-term upside even if their long-term fundamentals remain sound.

Positive Factors

Broad International Diversification

The fund spreads its investments across many countries, with meaningful exposure to Japan, the UK, and several major European markets, which helps reduce reliance on any single economy.

Balanced Sector Mix

Holdings are spread across financials, industrials, consumer, technology, health care, and other sectors, helping to cushion the impact if one industry struggles.

Competitive Expense Ratio

The ETF charges a relatively low fee, so less of your potential return is lost to ongoing costs.

Negative Factors

Heavy Tilt Toward Financials

Financial stocks make up a large share of the portfolio, which can increase sensitivity to interest rate changes and banking sector stress.

Mixed Performance Among Top Holdings

While some major positions like ASML and Mitsubishi UFJ have shown strong gains, others such as Nestlé, Royal Bank of Canada, and AstraZeneca have been weaker, creating uneven contribution to returns.

Limited U.S. Market Exposure

The fund has only a small allocation to U.S. stocks, so investors who want significant exposure to the U.S. market would need to pair this ETF with other holdings.

INTF vs. SPDR S&P 500 ETF (SPY)

AUM3.25B

RegionDeveloped Markets

Expense Ratio0.16%

Beta0.71

IssueriShares

Inception DateApr 28, 2015

Dividend Yield2.63%

Asset ClassEquity

Index TrackedSTOXX International Equity Factor

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume218,478

30 Day Avg. Volume202,756

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

44.16

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering463

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

INTF Summary

INTF is the iShares MSCI Intl Multifactor ETF, which follows the STOXX International Equity Factor index. It invests in a wide mix of companies outside the U.S., with big exposure to countries like Japan, the UK, and France, and sectors such as financials and industrials. Well-known holdings include Novartis and ASML. The fund uses a rules-based approach to pick stocks it sees as higher quality or better value, which may help with long-term growth and diversification beyond the U.S. stock market. A key risk is that international stocks can be volatile and are affected by currency and global economic swings.

How much will it cost me?The iShares MSCI Intl Multifactor ETF (INTF) has an expense ratio of 0.16%, which means you’ll pay $1.60 per year for every $1,000 invested. This is lower than average because it’s passively managed, focusing on tracking a multifactor index rather than active stock selection.

What would affect this ETF?The iShares MSCI Intl Multifactor ETF (INTF) could benefit from growth in developed markets outside the U.S., especially if sectors like financials and technology perform well, as they make up a significant portion of the fund. However, challenges such as rising interest rates or economic slowdowns in these regions could negatively impact key holdings like Novartis and ASML, as well as broader sector performance. Regulatory changes or geopolitical tensions in developed markets may also influence the ETF's future returns.

INTF Top 10 Holdings

INTF leans heavily on non-U.S. blue chips, with Europe and Japan doing most of the heavy lifting. ASML has been the clear engine of recent gains, riding strong momentum in the semiconductor space, while Mitsubishi UFJ and HSBC add extra fuel from a rising global banking backdrop. Novartis and Roche keep the health care side of the portfolio steadily humming. On the flip side, consumer giant Nestlé has been losing steam, and AstraZeneca has been more of a quiet passenger than a driver, but neither is big enough to derail the fund’s diversified, factor-driven approach.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NOVN	Novartis AG	2.17%	$70.46M	CHF228.77B	23.42%	80 Outperform
ASML	ASML Holding NV	2.11%	$68.33M	€460.22B	65.75%	76 Outperform
ROG	Roche Holding AG	1.14%	$37.11M	CHF282.72B	43.82%	73 Outperform
RY	Royal Bank Of Canada	1.02%	$33.08M	$244.36B	47.04%	75 Outperform
NESN	Nestlé SA	0.99%	$32.01M	CHF198.27B	20.08%	71 Outperform
ABB	ABB Ltd	0.96%	$31.04M	kr1.44T	35.30%	78 Outperform
8411	Mizuho Financial Group	0.94%	$30.47M	¥18.79T	68.71%	77 Outperform
AZN	AstraZeneca	0.93%	$30.28M	£215.33B	21.85%	80 Outperform
HSBA	HSBC Holdings	0.92%	$29.70M	£226.51B	49.15%	80 Outperform
8306	Mitsubishi UFJ Financial Group	0.91%	$29.49M	¥33.07T	58.13%	76 Outperform

INTF Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

38.32

Positive

100DMA

37.02

Positive

200DMA

35.26

Positive

Market Momentum

MACD

0.65

Negative

RSI

68.90

Neutral

STOCH

64.30

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For INTF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 39.62, equal to the 50-day MA of 38.32, and equal to the 200-day MA of 35.26, indicating a bullish trend. The MACD of 0.65 indicates Negative momentum. The RSI at 68.90 is Neutral, neither overbought nor oversold. The STOCH value of 64.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for INTF.

INTF Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
INTF	―	―	$3.25B	0.16%	―
GSIE	―	―	$5.30B	0.25%	―
LVHI	―	―	$4.26B	0.40%	―
IMTM	―	―	$3.65B	0.30%	―
IDMO	―	―	$2.97B	0.25%	―
PXF	―	―	$2.47B	0.43%	―

Performance Comparison

INTF

iShares MSCI Intl Multifactor ETF

41.17

11.69

39.65%

GSIE

Goldman Sachs ActiveBeta International Equity ETF

―

LVHI

Legg Mason International Low Volatility High Dividend ETF

―

IMTM

iShares MSCI Intl Momentum Factor ETF

―

IDMO

Invesco S&P International Developed Momentum ETF

―

PXF

Invesco FTSE RAFI Developed Markets ex-U.S. ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents